AssetMark Inc
SYNH

AssetMark Inc’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

AssetMark Inc’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-797
Closed -$33.6K – 1820
2023
Q2 		$33.6K Sell
797
-1,102
-58% -$44.6K ﹤0.01% 1148
2023
Q1 		$67.6K Sell
1,899
-19
-1% -$689 ﹤0.01% 968
2022
Q4 		$70.4K Sell
1,918
-131
-6% -$5.18K ﹤0.01% 968
2022
Q3 		$97K Buy
2,049
+343
+20% +$22.2K ﹤0.01% 854
2022
Q2 		$122K Buy
1,706
+404
+31% +$29.5K ﹤0.01% 795
2022
Q1 		$105K Buy
1,302
+301
+30% +$25.5K ﹤0.01% 785
2021
Q4 		$103K Hold
1,001
– – ﹤0.01% 783
2021
Q3 		$88K Sell
1,001
-25
-2% -$2.26K ﹤0.01% 670
2021
Q2 		$92K Sell
1,026
-89
-8% -$7.52K ﹤0.01% 646
2021
Q1 		$85K Buy
1,115
+26
+2% +$1.96K ﹤0.01% 643
2020
Q4 		$74K Sell
1,089
-150
-12% -$9.35K ﹤0.01% 644
2020
Q3 		$66K Hold
1,239
– – ﹤0.01% 636
2020
Q2 		$72K Buy
1,239
+125
+11% +$6.72K ﹤0.01% 609
2020
Q1 		$44K Sell
1,114
-170
-13% -$9.94K ﹤0.01% 715
2019
Q4 		$76K Hold
1,284
– – ﹤0.01% 668
2019
Q3 		$68K Buy
1,284
+120
+10% +$6.16K ﹤0.01% 667
2019
Q2 		$59K Hold
1,164
– – ﹤0.01% 678
2019
Q1 		$60K Sell
1,164
-8
-0.7% -$388 ﹤0.01% 667
2018
Q4 		$46K Sell
1,172
-94
-7% -$4.37K ﹤0.01% 706
2018
Q3 		$65K Hold
1,266
– – ﹤0.01% 687
2018
Q2 		$59K Buy
1,266
+331
+35% +$13.7K ﹤0.01% 686
2018
Q1 		$33K Hold
935
– – ﹤0.01% 841
2017
Q4 		$41K Buy
935
+18
+2% +$841 ﹤0.01% 838
2017
Q3 		$48K Hold
917
– – ﹤0.01% 715
2017
Q2 		$54K Hold
917
– – ﹤0.01% 666
2017
Q1 		$42K Buy
917
+31
+3% +$1.54K ﹤0.01% 688
2016
Q4 		$47K Hold
886
– – ﹤0.01% 635
2016
Q3 		$40K Buy
+886
New +$38.4K ﹤0.01% 681

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AssetMark Inc's SYNH Position: Q3 2023 in Review

AssetMark Inc sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 797 shares — an estimated $33.6K sold.

AssetMark Inc first reported a position in SYNH in Q3 2016 and held it in 28 quarters. The position peaked at $122K in Q2 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • AssetMark Inc reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • AssetMark Inc sold 797 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $33.6K.
  • AssetMark Inc first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 28 quarters.
  • AssetMark Inc's Syneos Health, Inc. Class A Common Stock position peaked at $122K in Q2 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on AssetMark Inc's 13F filing for Q3 2023, filed 27 Oct 2023.